-+ 0.00%
-+ 0.00%
-+ 0.00%

NewGenIvf closes USD 1.25 million public share offering

PUBT·09/30/2026 18:12:59
NewGenIvf closes USD 1.25 million public share offering
  • NewGenIvf closed a reasonable best-efforts public offering raising about $1.25 million in gross proceeds.
  • Deal included 17,857,143 Class A ordinary shares or pre-funded warrants, including 125,000 shares.
  • Pricing set at $0.07 per share, $0.06999 per pre-funded warrant, with a $0.00001 exercise price.
  • Pre-funded warrants are immediately exercisable, remaining exercisable until fully exercised.
  • Closing occurred Sept. 30, 2026; net proceeds earmarked for K25.ai investment, debt restructuring, working capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewGenIvf Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609301410PRIMZONEFULLFEED9837192) on September 30, 2026, and is solely responsible for the information contained therein.